| Term 
 | Definition 
 
        | antidote: 
 LEUCOVORIN--> (folinic acid) to rescue host cells while cancer cells are less affected |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antidotes: 
 • MESNA--> (2 mercaptoethane sulphonate) conjugates toxic metabolites such as acrolein in the urine and helps to reduce the chemical cystitis. • DEMECLOCYCLINE--> blocks the effects of ADH |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antidote: 
 AMIFOSTINE--> generates active thiol metabolites, which scavenge free radicals |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antidotes: DIMETHYL SULFOXIDE--> swabbed onto free radical induced ulcers to stop production DEXRAZOXANE-->an iron chelator , reduces the cardiomyopathy damage induced by doxorubicin   |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimetabolite ;DOC for AML; MOA :-blocks DNA strand elongation;neurotoxic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Oral prodrug, converted to 5-fluorouracil. It inhibits thymidylate synthase. Useful for paclitaxel and doxorubicin - resistant patients with colorectal or metastatic breast cancers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alkylating agent	- toxic to the CNS-used for CNS cancers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stabilizes the topoisomerase II-DNA complex causing double strand DNA breaks during DNA replication. Dose limiting leukopenia. Treats first time, and metastatic testicular cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | UniqueTopoisomerase 1 inhibitor, preventing religation of bits of helices; causes accumulation of single stranded breaks in DNA. Dose -limiting neutropenia |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonsteroidal androgen antagonist (NSAA )which inhibits the translocation of steroid receptors to the nucleus . 5-alpha reductase inhibitor-inhibits synthesis of dihydrotestosterone .Both used to treat prostate cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonsteroidal androgen antagonist (NSAA )which inhibits the translocation of steroid receptors to the nucleus . 5-alpha reductase inhibitor-inhibits synthesis of dihydrotestosterone .Both used to treat prostate cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GnRH analogues which acts as a partial agonists at GnRH receptors. When administered in constant doses to maintain stable blood levels, it inhibit the release of LH and FSH. Used in the treatment of prostate cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | This is an unconjugated chimeric(murine/human)antiCD20 monoclonal antibody which binds to the CD20 antigen on follicular B cells in Non Hodgkins lymphoma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiestrogen for hormone-sensitive tumors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits bcr-abl tyrosine kinase found in chronic myelocytic leukemia(CML) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits ribonucleotide reductase ; stops conversion of ribonucleotides to deoxyribonucleotides.;for myeloproliferative disorders |  | 
        |  | 
        
        | Term 
 
        | what are the two major categories of anticancer drugs? |  | Definition 
 
        | CYTOTOXIC DRUGS- effect both cancer and normal cells-->especially dividing cells NEWER DRUGS-target entities in the cancer cells which are absent or different in normal cells
 |  | 
        |  | 
        
        | Term 
 
        | how is RESISTANCE developed in cancer cells vs. drugs that first need to be activated before affects are seen? |  | Definition 
 
        | resistance is achieved when cancer cell can limit/stop ACTIVATING ENZYME |  | 
        |  | 
        
        | Term 
 
        | what is DOSE LIMITING TOXICITY? |  | Definition 
 
        | Drug toxicity towards a particular organ is so serious that it puts a limit on the dose of that drug that may be used in treatment--> DOXORUBICIN in the heart |  | 
        |  |